HUGE news with the approval today of pembrolizumab for PD-L1+ cervical cancer... An exciting new option for patients with previously-treated advanced disease.

https://www.onclive.com/web-exclusives/fda-approves-pembrolizumab-for-pdl1-cervical-cancer